Value-Creation Simulator

Pick a scenario or pull the levers — see profit, cash, leverage, covenant headroom and enterprise value move in real time, then stress-test it with AI.

Syngenta · FY25 (modeled)

Top 3 global crop science company

49,000 employees · 12+ US sites · 100 countries

Scenarios

Pull the levers

Collect faster (DSO)

High6d

One-time working-capital release+$279.5M cash

Lift recurring mix

Med3pt

Shift project work to annuity (~8pt margin premium)+$40.8M EBITDA

Capture cross-sell

Med25%

of $1.20B whitespace → $300.0M revenue+$75.0M EBITDA

Operational gains

High1pt

SG&A synergy · utilization · first-time-fix+$173.0M EBITDA

EV / EBITDA multiple

Market12x

Valuation lens for the Board / PE owner

Recurring carries ~8pt EBITDA premium · cross-sell at 25% incremental margin, 60% recurring · DSO release is one-time working capital · EV at the chosen multiple. Illustrative model on modeled baseline figures.

Enterprise value

$43.45B+$3.47B

from $39.98B baseline · at 12× EBITDA

Rule of 40 (growth + margin)23 → 26

white line = 40, the healthy-platform threshold

Cash freed

$279M

one-time, from −6d DSO

Lands in 0–6 months · funds the next acquisition with no new sales.

EBITDA bridge · $3.33B → $3.62B+$289M (20.9% margin)

$3.33B

+$173M

+$75M

Operational gains+$173.0M

Cross-sell whitespace+$75.0M

Recurring mix shift+$40.8M

Ranked by EBITDA contribution — the top bar is the biggest lever in this scenario. (DSO shows as cash, not EBITDA.)

Baseline → scenario

Metric	Today		Scenario	Δ
Revenue	$17.00B	→	$17.30B
Adj. EBITDA	$3.33B	→	$3.62B
EBITDA margin	19.6%	→	20.9%	+1.3pt
ARR (recurring)	$320M	→	$1.01B	mix 6%
Net leverage	2.10x	→	1.86x	-0.24x
Enterprise value	$39.98B	→	$43.45B	+$3.47B
Rule of 40	23	→	26

Covenant headroom3.64x below the 5.5x ceiling

5.5x covenant

scenario 1.86xtoday 2.10x (line)